Career & Filing History
Every role Richard G. Kyle has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Richard G. Kyle serves as Advisor to the CEO of TIMKEN CO (TKR). Kyle has also held reporting roles at SONOCO PRODUCTS CO (SON) and Sotera Health Co (SHC). Kyle has reported 26 insider filings with the SEC since 2024. The most recent filing was in August 2026.
Every role Richard G. Kyle has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
TIMKEN CO (TKR)1 filingSONOCO PRODUCTS CO (SON)2 filingsUpdated Aug 30, 2026
Richard G. Kyle is Director of TIMKEN CO (TKR). 26 SEC Form 4 filings on record going back to 2024, most recently on 11 August 2026. Most recent open-market trade: sold $1.73M of TKR on 11 August 2026. Lifetime open-market sales: $19.61M.
Every recent SEC Form 4 transaction Richard G. Kyle has reported, most recent first.
InsiderAlpha's records for Richard G. Kyle go back to 2024: 26 primary Form 4 filings, an average of 8.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Richard G. Kyle files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Richard G. Kyle is a corporate insider, tracked as Director of TIMKEN CO (TKR). InsiderAlpha holds 26 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases and 11 open-market sales ($19.61M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$SHC Sotera Health Co15.0K shares @ $0.00-